Condition: Invasive Breast Cancer · Stage III Breast Cancer · Stage IIB Breast Cancer · Sponsor: Dr. Tabassum Wadasadawala
This clinical research aims to determine if concurrent chemotherapy and radiation therapy is more effective than sequential chemotherapy and radiation therapy for patients with stage IIB-III breast cancer. It seeks to answer the following key questions: 1. When compared to sequential treatment, does concurrent chemoradiotherapy increase disease-free survival? 2. What effects does concurrent treatment have on post-operative look, quality of life, and side effects including arm swelling (lymphoedema)? 3. What are each treatment approach's financial costs? Researchers will compare the following to groups: Arm A: Participants in the sequential treatment group will first undergo chemotherapy and then radiation. and Arm B: Participants in the concurrent treatment group will undergo radiation therapy while undergoing chemotherapy. Participants are going to: 1. Get the usual chemotherapy (taxanes and/or anthracyclines). 2. Receive radiation therapy for three to four weeks. 3. Have follow-up visits every 6months for 5years to check for cancer recurrence, side effects, and quality of life.
This description comes directly from the study's public registry record.
Tabassum Wadasadawala, MD, DNB Radiotherapy · (+91-22) 24177026 · drtabs.radonc@gmail.com
Always discuss trial participation with your own doctor first.
| Homi Bhabha Cancer Hospital & Research Centre | Vishkhapatnam, Andhra Pradesh, India | Not Yet Recruiting |
| Tata Memorial Centre | Mumbai, Maharasthra, India | Recruiting |
| Homi Bhabha Cancer Hospital and Research Centre | New Chandigarh, Punjab, India | Not Yet Recruiting |
| Homi Bhabha Cancer Hospital, Sangrur | Sangrur, Punjab, India | Not Yet Recruiting |
| Mahamana Pandit Madan Mohan Malviya Cancer Centre | Varanasi, Uttar Pradesh, India | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06926543